Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders
Chengran Yang, Fabiana Farias, Laura Ibáñez, et al.
Nature Neuroscience (2021) Vol. 24, Iss. 9, pp. 1302-1312
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

Stroke genetics informs drug discovery and risk prediction across ancestries
Aniket Mishra, Rainer Malik, Tsuyoshi Hachiya, et al.
Nature (2022) Vol. 611, Iss. 7934, pp. 115-123
Open Access | Times Cited: 338
Measuring biological age using omics data
Jarod Rutledge, Hamilton Oh, Tony Wyss‐Coray
Nature Reviews Genetics (2022) Vol. 23, Iss. 12, pp. 715-727
Open Access | Times Cited: 301
Emerging diagnostics and therapeutics for Alzheimer disease
Wade Self, David M. Holtzman
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2187-2199
Closed Access | Times Cited: 184
Large-scale plasma proteomics comparisons through genetics and disease associations
Grímur Hjörleifsson Eldjárn, Egil Ferkingstad, Sigrún H. Lund, et al.
Nature (2023) Vol. 622, Iss. 7982, pp. 348-358
Open Access | Times Cited: 167
Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis
Jianfeng Lin, Jiawei Zhou, Yan Xu
Brain (2023) Vol. 146, Iss. 8, pp. 3364-3372
Open Access | Times Cited: 162
Advances in the development of new biomarkers for Alzheimer’s disease
Timofey O. Klyucherev, Pawel K. Olszewski, Alena A. Shalimova, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 159
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Iris E. Jansen, Sven J. van der Lee, Duber Gomez‐Fonseca, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 5, pp. 821-842
Open Access | Times Cited: 85
Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life
Keenan A. Walker, Jingsha Chen, Shi Liu, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 705
Open Access | Times Cited: 72
Plasma proteomic profiles predict individual future health risk
Jia You, Yu Guo, Yi Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 54
The role of peripheral inflammatory insults in Alzheimer’s disease: a review and research roadmap
Keenan A. Walker, Lydia M. Le Page, Niccolò Terrando, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 48
Mendelian Randomization Applied to Neurology
Éloi Gagnon, Iyas Daghlas, Loukas Zagkos, et al.
Neurology (2024) Vol. 102, Iss. 4
Open Access | Times Cited: 21
Addressing the credibility crisis in Mendelian randomization
Stephen Burgess, Benjamin Woolf, Amy M. Mason, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Plasma proteome variation and its genetic determinants in children and adolescents
Lili Niu, Sara Stinson, Louise Aas Holm, et al.
Nature Genetics (2025)
Open Access | Times Cited: 2
Identification of novel drug targets for Alzheimer’s disease by integrating genetics and proteomes from brain and blood
Ya‐Nan Ou, Yuxiang Yang, Yue‐Ting Deng, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 6065-6073
Closed Access | Times Cited: 71
Epigenetics in Alzheimer’s Disease
Xiaodie Gao, Qiang Chen, Hua Yao, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 57
Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases
Huiling Zhao, Humaria Rasheed, Therese Haugdahl Nøst, et al.
Cell Genomics (2022) Vol. 2, Iss. 11, pp. 100195-100195
Open Access | Times Cited: 50
Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer’s disease
Yun Ju Sung, Chengran Yang, Joanne Norton, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 703
Open Access | Times Cited: 40
Mendelian randomization as a tool to inform drug development using human genetics
Iyas Daghlas, Dipender Gill
Cambridge Prisms Precision Medicine (2023) Vol. 1
Open Access | Times Cited: 37
Cerebrospinal Fluid–Basic Concepts Review
N. Czarniak, Joanna Kamińska, Joanna Matowicka-Karna, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1461-1461
Open Access | Times Cited: 37
Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease
Daniel J. Panyard, Justin McKetney, Yuetiva Deming, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 12, pp. 5447-5470
Open Access | Times Cited: 26
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer’s disease
Carlos Cruchaga, Daniel Western, Jigyasha Timsina, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 26
A multi-ancestry genetic study of pain intensity in 598,339 veterans
Sylvanus Toikumo, Rachel Vickers‐Smith, Zeal Jinwala, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 1075-1084
Open Access | Times Cited: 14
Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s disease
Yu Guo, Shi-Dong Chen, Jia You, et al.
Nature Human Behaviour (2024) Vol. 8, Iss. 10, pp. 2047-2066
Closed Access | Times Cited: 13
Epigenetic dysregulation in Alzheimer’s disease peripheral immunity
Abhirami Ramakrishnan, Natalie Piehl, Brooke Simonton, et al.
Neuron (2024) Vol. 112, Iss. 8, pp. 1235-1248.e5
Closed Access | Times Cited: 12
Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease
Abdallah M. Eteleeb, Brenna C. Novotny, Carolina Soriano‐Tárraga, et al.
PLoS Biology (2024) Vol. 22, Iss. 4, pp. e3002607-e3002607
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top